Clinical Significance of Preoperative Albumin and Globulin Ratio in Patients with Gastric Cancer Undergoing Treatment

Table 2

Prognostic value of AGR for overall survival in the testing group of GC patients by univariate and multivariate analyses.

Characteristics	Univariate analysis			Multivariate analysis
	Hazard ratio	95% CI	p value	Hazard ratio	95% CI	p value
Sex
Male versus female	0.886	0.603–1.302	0.538
Age (yr)
≤59 versus >59	1.313	0.922–1.870	0.131
Primary tumor size (cm)
<4.0 versus ≥4.0	1.855	1.182–2.909	0.007	1.451	0.828–2.544	0.193
Tumor location
Proximal versus remote versus other	1.366	1.046–1.784	0.022	1.224	0.864–1.735	0.255
Degree of differentiation
Poorly versus moderately versus well	1.080	0.560–2.083	0.818
Distant metastasis
No versus yes	6.989	4.776–10.228	<0.001	2.361	1.216–4.585	0.011
Surgery
No versus yes	0.509	0.337–0.768	<0.001	1.467	0.745–2.887	0.268
TNM category (AJCC, 7th)
I + II versus III + IV	4.577	2.859–7.326	<0.001
NLR
≤2.08 versus >2.08	1.959	1.344–2.855	<0.001	1.269	0.748–2.153	0.378
PLR
≤140.63 versus >140.63	1.923	1.330–2.778	0.001	1.106	0.628–1.950	0.727
AGR
≤1.50 versus >1.50	0.626	0.438–0.859	0.010	0.584	0.351–0.973	0.039